International Public Partnerships buys Frankfurt cop shop – International Public Partnerships Limited has entered into a binding commitment to acquire a stake in the new public private partnership police centre of South-East Hesse in Offenbach. International Public Partnerships has committed to invest c.EUR8 million for a 45% shareholding in the project. The project has been […]
Edinburgh Worldwide gets new deputy managers – Following discussion between the board and managers, Edinburgh Worldwide has announced the appointment of Svetlana Viteva and Luke Ward as deputy portfolio managers with immediate effect. Svetlana and Luke are part of Baillie Gifford’s Global Discovery investment team which is headed by Douglas Brodie, the manager of Edinburgh Worldwide. This […]
Isaly steps down from OrbiMed and Worldwide Healthcare Trust Veteran US biotech analyst and OrbiMed Capital founder Samuel Isaly has stepped down from his role as Managing Partner and separately as a director of UK-listed Worldwide Healthcare Trust WWH, which is managed by OrbiMed alongside Biotech Growth Trust BIOG. Isaly will be replaced at the New […]
JPMorgan Elect will introduce borrowings in income pool – JPMorgan Elect has published its annual report covering the year ended 31 August 2017. The Managed Growth portfolio delivered a total return on net assets of 20.2%, compared with the portfolio’s benchmark which returned 16.7%. The share price total return was 19.6%. For the year ended 31st […]
Gilead acquires Cell Design Labs to bolster CAR-T presence Leading US biotech Gilead Sciences is to acquire privately-held Cell Design Labs in a structured buy out valued at to $567m, including the 12.2% shareholding it already holds as a result of its $12bn acquisition of Kite Pharmaceuticals earlier this year. The Kite deal propelled Gilead […]
Alexion stock rises on reports of activist investor – Stock in the US rare disease specialist Alexion Pharmaceuticals is up 6% this morning on reports that the famed New York-based activist hedge fund Elliot Management has taken a stake. Elliott has reportedly threatened to initiate a proxy battle potentially to replace the relatively new management team […]
Electra underperforms as it shrinks – Electra Private Equity reports that, for the year ended 30 September 2017, its NAV total return was 9%, well behind that of the Mid 250 Index at 14%. Including their third special dividend announced 23 October 2017, they have returned GBP1.8bn to shareholders since 1 October 2016. The shareholder return was […]
For the year ended 30 September 2017, Invesco Perpetual Enhanced Income Limited “performed strongly” with a total return to shareholders, based on the share price with dividends reinvested, of 10.5%. The share price rose from 77.4p at the start of the year to 80.3p, an increase of 3.7%. The managers earned a £1m performance fee. […]
F&C Capital and Income continues record of outperformance – F&C Capital and Income announces, for the year ended 30 September 2017: Share price total return for the year was 15.8%, with an average premium to Net Asset Value of 1.6%. Total ordinary dividends of 10.65 pence per share – an increase of 3.4% over the previous […]
Schroder Asia Pacific beats benchmark – Schroder AsiaPacific Fund has published its annual report for the year ended 30 September 2017. The NAV total return was +23.2% over the twelve months to end September 2017. This was ahead of the performance of the benchmark, the MSCI All Country Asia ex Japan Index, which was up +18.8% […]
